A comparison of recombinant hirudin with heparin for the treatment of acute coronary syndromes. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIb investigators. N Engl J Med. 1996;335(11):775-782. 61. EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high- risk coronary angioplasty. The EPIC Investigation. N Engl J Med. 1994;330(14):956-961. 62. EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med. 1997;336(24): 1689-1696. 63. Landefeld CS, Cook EF, Flatley M, Weisberg M, Goldman L. Identi cation and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagu- lant therapy. Am J Med. 1987;82(4):703-713. 64. Landefeld CS, McGuire E III, Rosenblatt MW. A bleeding risk index for estimating the probability of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med. 1990;89(5):569-578. 65. Raschke RA, Gollihare B, Peirce JC. The effectiveness of implementing the weight-based heparin nomogram as a practice guideline. Arch Intern Med. 1996;156(15):1645-1649. 66. Basu D, Gallus A, Hirsh J, Cade J. A prospective study of the value of monitoring heparin treatment with the activated par- tial thromboplastin time. N Engl J Med. 1972;287(7):324-327. 67. Bain B, Forster T, Sleigh B. Heparin and the activated partial thromboplastin time a difference between the 2012 American College of Chest Physicians by Kimberly Henricks on February 10, 2012 chestjournal.chestpubs.org Downloaded from www.chestpubs.org CHEST / 141 / 2 / FEBRUARY, 2012 SUPPLEMENT e39S thromboplastin time in cardiac surgical patients. Anesth Analg. 1994;79(4):670-674. 105. D Ambra M. Restoration of the normal coagulation process: advances in therapies to antagonize heparin. J Cardiovasc Pharmacol. 1996;27(suppl 1):S58-S62. 106. Dehmer GJ, Fisher M, Tate DA, Teo S, Bonnem EM. Reversal of heparin anticoagulation by recombinant platelet factor 4 in humans. Circulation. 1995;91(8):2188-2194. 107. 